Skip to main content

Table 3 Study and patient characteristics extracted from included studies

From: Evidence for pharmacological interventions to reduce cardiovascular risk for patients with chronic kidney disease: a study protocol of an evidence map

Study characteristics

 Name of trial

Follow-up

Subgroup analysis on kidney function or disease

 NCT number

Sample size

Restriction of study population to patients with reduced kidney function

 Region

Type of intervention

Hypertension, blood pressure, or use of antihypertensive exclusion criterionb

 Year of publication

Reported outcomes

Diabetes, HbA1c, or use of anti-glycaemic agent exclusion criterionb

 Funding source

Kidney function or disease exclusion criteriona,b

Smoking exclusion criterionb

Patient characteristics

 Age

  

 Sex

Undergoing dialysis

 

 Baseline kidney function

  
  1. aDefined as exclusion criterion based on eGFR, serum creatinine, kidney disease, renal insufficiency, end-stage kidney disease, dialysis, or ambiguous kidney exclusion criterion
  2. bIf not specifically specified, presume that the respective group of patients is included in the trial